How MoniDose strengthened their regulatory confidence—fast

When MoniDose began their startup journey, regulations were their biggest challenge. Missing early design inputs tied to standards could have meant costly redesigns later.

Sprint Bioscience builds the molecules that will become new medicines

In Sprint Bioscience’s laboratory in Flemingsberg, Huddinge, molecules are being created that no one has ever built before. The company specializes in preclinic...

Nordic collaboration delivering the next leap in spatial biology

Spatial biology is reshaping how researchers understand complex tissue environments, from tumour–immune interactions to treatment response. A major barrier has ...

Important notification for IVDR Class C device manufacturers

Deadline for application is quickly approaching; 26 May 2026.

Atrogi on its challenger to GLP-1: “Now we are stepping forward”

A new approach to treating type 2 diabetes and obesity is taking shape in a laboratory just a stone’s throw from the Karolinska Institute. At Atrogi, researcher...

Paul Chaplin steps down as CEO of Bavarian Nordic

Danish vaccine company Bavarian Nordic’s CEO, Paul Chaplin, is stepping down from his position for personal reasons.

End of bone‑sawing? New laser cuts to record depths

Saw, drill and chisel are a bone surgeon’s best friends today – but soon the laser may also find its place in that toolbox. Researchers in Switzerland have disc...

Networking event in Denmark: Sponsor Oversight in Clinical Trials

We are excited to invite clinical trial professionals to a networking event to connect and discuss best practices, challenges and adaptive strategies in documen...

A cluster contribution to European life science innovation and competitiveness?

Supporting Investigator Initiated Clinical Studies—From Start to Finish

Many important clinical studies start with researchers – not pharmaceutical companies. In investigator initiated studies, pharmaceutical companies often support...

New antibody aims to slow kidney damage – “It’s kind of cool”

For 25 years, Marie Jeansson has studied the kidney and its blood vessels. She is now working on developing a drug intended to slow down chronic kidney disease.

Lost in the recruitment process? How hiring really works today

As recruitment becomes increasingly automated, candidates are expected to adapt to both human and algorithmic decision-making. Career coach Tina Persson outline...

More than 150 jobs cut as Merck scales back vaccin production

Merck & Co, known as MSD in Europe, is hitting the brakes following a sharp decline in demand for its HPV vaccine Gardasil. Production at its facility in Durham...

Novo Nordisk strengthens board after turbulent year

Changes to Novo Nordisk’s board continue. Following last year’s sweeping restructuring, the Danish obesity drugmaker is now nominating two new directors with ex...

New ZEISS Crossbeam 750 FIB-SEM for high-accuracy sample preparation workflows

Advances in simultaneous SEM imaging while FIB milling provide unmatched feedback for precision endpointing.

Anna Törner: ”Drug prices – an important driver of innovation”

We live under the illusion that no price is too high when it comes to health, but that simply isn’t true, writes Anna Törner.

We are expanding our English-language coverage

Over a period of four weeks, one of Life Science Sweden's regular daily newsletters is being published entirely in English. The aim is to meet increasing demand...

New treatment recommended for children with brain tumours

The European Medicines Agency has recommended conditional approval of a new targeted treatment for children with the brain tumour pediatric low-grade glioma.

Meet ZEISS at ELRIG Advances in Cell-based Screening 2026

Reserve your spot now.

Cinclus welcomes FDA announcement on single‑study requirement

Swedish Cinclus Pharma welcomes the signals from the United States that a single pivotal study, rather than two, may be sufficient when applying for market approval.

Multicancer test failed to meet its goal – shares plunged

A blood test designed to detect multiple types of cancer failed to meet its primary endpoint in a large UK study. The company behind the test saw its market value cut in half.

ISO 13485 Standard Internal Auditing Course

Do you work with medical devices and quality management? Strengthen your expertise with our ISO 13485 Standard Internal Auditing Training — designed to give you...

Painkiller cuts recurrence risk by more than 50% – national guidelines updated

Sweden’s national guidelines for colon and rectal cancer have been updated — just nine months after the previous revision. The move follows new Swedish research...

Clinical evaluation of class I medical devices

The Swedish Medtech Regulatory Summit is just around the corner — taking place on March 12th at Hilton Slussen in Stockholm. We’re proud to share that our Senio...